Trial record 4 of 8 for:    Ixmyelocel-T

Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia (RESTORE-CLI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00468000
Recruitment Status : Completed
First Posted : May 1, 2007
Last Update Posted : July 1, 2016
Information provided by (Responsible Party):
Vericel Corporation